Grazax, Lyophilisat zum Einnehmen
7680578500015
CH-57850
Lyophilisat
Associated product:
GRAZAX Lyophilisat oral 75000 SQ-T 30 x 1 dos
1 / 3
google
Article details
- Package size
- 30
- Selling units
- 30
- Measure
- Einzeldose(n)
- Galenic form
- Lyophilisat
- Galenic group
- Lösbar zur Injektion/Infusion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
75000.0 U | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
12.7 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.54 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 110.85
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/01/2009
Authorization holder
ALK-Abelló AG
8304 Wallisellen
Authorization information
- Swissmedic authorization number
- 57850
- Drug name
- Grazax, Lyophilisat zur sublingualen Anwendung
- Galenic form
- LYSUV
- ATC Code
- V01AA02
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 29/06/2007
- Authorization expiration date
- 31/12/9999
- IT Number
- 07.13.3.
- Domain
- Human medicine
Package details
- Description (FR)
- GRAZAX Lyophilisat oral 75000 SQ-T 30 x 1 dos
- Description (DE)
- GRAZAX Lyophilisat oral 75000 SQ-T 30 x 1 Dos
- Market launch
- 29/06/2007
- Narcotic (BTM)
- No
Other package sizes (1)
GRAZAX Lyophilisat oral 75000 SQ-T 100 x 1 dos
100 EINZ
GTIN: 7680578500022